Sunday, April 20, 2014
Inquirer Daily News

J&J and Sanofi have pending deal on pieces of McNeil, but not Fort Washington plant

Drugmakers Johnson & Johnson and Sanofi have a pending deal involving an element of J&J's consumer products subsidiary, McNeil PPC Inc., according to a posting on the Federal Trade Commission web site.

J&J and Sanofi have pending deal on pieces of McNeil, but not Fort Washington plant

This global powerhouse is based in New Brunswick, N.J. It was founded in 1887 and today boasts a multi-faceted business with more than 117,900 employees, 200 subsidiaries and a market cap of $198 billion. Products include Tylenol, Zyrtec, Benadryl; Band-Aid; Acuevue contact lenses. And much more. J&J expanded into pharmaceuticals in the 1970s and 1980s through acquisition. Recently, it has had to contend with product recalls at its McNeil unit; bone cement from Synthes, which it acquired in June; and settlements and lawsuits involving the marketing of anti-psychotic drug Risperdal.<p><b>SEE A PREVIEW OF NEXT WEEK´S SLIDESHOW BY CLICKING THE RIGHT SIDE OF THE IMAGE.</b></p>
This global powerhouse is based in New Brunswick, N.J. It was founded in 1887 and today boasts a multi-faceted business with more than 117,900 employees, 200 subsidiaries and a market cap of $198 billion. Products include Tylenol, Zyrtec, Benadryl; Band-Aid; Acuevue contact lenses. And much more. J&J expanded into pharmaceuticals in the 1970s and 1980s through acquisition. Recently, it has had to contend with product recalls at its McNeil unit; bone cement from Synthes, which it acquired in June; and settlements and lawsuits involving the marketing of anti-psychotic drug Risperdal.

SEE A PREVIEW OF NEXT WEEK'S SLIDESHOW BY CLICKING THE RIGHT SIDE OF THE IMAGE.

Drugmakers Johnson & Johnson and Sanofi have a pending deal involving an element of J&J’s consumer products subsidiary, McNeil PPC Inc., according to a posting on the Federal Trade Commission web site.

But the deal will not include selling the McNeil Consumer Healthcare facility in Fort Washington, Montgomery County, according to McNeil spokeswoman Barbara Montresor.

McNeil PPC has several units, including McNeil Consumer Healthcare, and products such as Band Aids, Tylenol and Listerine.

Montresor declined comment on the specifics of the deal and whether there would be any employment impact in Fort Washington, which is undergoing repairs after production was halted in April 2010. The FDA and a federal judge will have to approve resumption of production.

“We continue to develop our manufacturing facility in Fort Washington, we have met all of our consent decree milestones and expect to be ready for FDA certification at the end of 2013,” Montresor said.

As for what brands might be going to Sanofi, Montresor said only, “We regularly evaluate our brand portfolio and consider growth options for all of the brands.”

Sanofi spokesman Jack Cox said, “We don’t comment on pending business development transactions.”

David Sell
About this blog
David Sell blogs about the region's pharmaceutical industry. Follow him on Facebook.

For Inquirer.com. Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Reach David at dsell@phillynews.com.

David Sell
Business Videos:
Also on Philly.com:
Stay Connected